13-cis retinoic acid inhibits growth of adult T cell leukemia cells and causes apoptosis; possible new indication for retinoid therapy

Intern Med. 1996 Mar;35(3):180-4. doi: 10.2169/internalmedicine.35.180.

Abstract

We evaluated the effects of 13-cis retinoic acid (13-cis RA) on the growth of peripheral blood mononuclear cells (PBMC) obtained from 12 patients with adult T cell leukemia (ATL). In general, 13-cis RA potently inhibited the growth of PBMC from ATL patients. However, the sensitivity of the cells to 13-cis RA-induced growth inhibition varied among the patients. The ATL patients fell into three groups (hypersensitive, sensitive and resistant to 13-cis RA) according to the percent reduction of 3H-thymidine incorporation before and after treatment with 13-cis RA. Agarose gel electrophoresis of total genomic DNA from a patient sensitive to 13-cis RA provided evidence of the DNA fragmentation indicative of apoptosis. The ability of 13-cis RA to induce apoptosis in PBMC from ATL patients suggests that retinoids may be useful in the treatment of ATL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis / drug effects*
  • Cell Division / drug effects
  • DNA Damage
  • DNA, Neoplasm / analysis
  • Electrophoresis, Agar Gel
  • Female
  • Genetic Markers
  • Humans
  • Isotretinoin / pharmacology*
  • Isotretinoin / therapeutic use
  • Keratolytic Agents / pharmacology*
  • Keratolytic Agents / therapeutic use
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Leukemia-Lymphoma, Adult T-Cell / pathology
  • Male
  • Middle Aged
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / pathology
  • Thymidine
  • Tumor Cells, Cultured

Substances

  • DNA, Neoplasm
  • Genetic Markers
  • Keratolytic Agents
  • Isotretinoin
  • Thymidine